Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
DOJ Reports $1.9 Billion in Health Care False Claims Act Recoveries for FY 2015
By Kelly A. Briganti, Editorial Director, G2 Intelligence Given the large False Claims settlements the laboratory sector has seen this year and the major nationwide Takedown initiatives, it's no surprise to hear the Department of Justice (DOJ) recovered $1.9...
LabCorp Acquires Pathology, Inc.
By Ron Shinkman, Editor, Laboratory Industry Report LabCorp will acquire a significant presence in women's health assays. The North Carolina-based LabCorp announced the acquisition of Pathology, Inc. on Dec. 10. Terms of the transaction were not disclosed. The lab...
ACLA, AHA Submit Comments to CMS Regarding PAMA Final Rules
...
Register
Boston Heart Diagnostics Makes Statin Adherence Test More Consumer Friendly
...
Register
Quest to Manage Barnabas Health’s Hospital Laboratories
By Ron Shinkman, Editor, Laboratory Industry Report Quest Diagnostics, which has been extending itself more into the operation of hospital laboratories in recent years, has just inked a deal to manage the labs owned by the largest hospital operator in its home...
FDA Workshop Addresses Security of Medical Devices
From - G2 Compliance Advisor
The U.S. Food and Drug Administration (FDA) is joining the cadre of government agencies calling attention to the cybersecurity risks of wireless, internet-and network-connected devices and…
Sonora Quest Laboratories Enters Into Draw Center Deal With Safeway
...
Register
FDA Issues Report Saying Many Laboratory-Developed Tests Are Dangerous
...
Register
Whistleblower Claims Lead to Big Settlements for Pathology Group and Laboratory
By Kelly A. Briganti, Editorial Director, G2 Intelligence Two separate False Claims Act cases initiated by whistleblowers have resulted in settlements for a North Carolina pathology group and a Wisconsin laboratory, its founders and a related company. In the first...
Philanthropy Giants Funding Medical Research
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Facebook founder Mark Zuckerberg grabbed headlines this week because of the letter he and his wife wrote to their newborn daughter announcing they will give 99 percent of their Facebook shares...